(Q40753771)

23 September 2017

title

CpG DNA as a Th1-promoting adjuvant in immunization against Trypanosoma cruzi (English)

1 reference

23 September 2017

0 references

0 references

Corral RS

1

1 reference

23 September 2017

Petray PB

series ordinal

2

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

23 September 2017

1 reference

23 September 2017

volume

19

1 reference

23 September 2017

issue

2-3

1 reference

23 September 2017

page(s)

234-242

1 reference

Trypanosoma cruzi: partial prevention of the natural infection of guinea pigs with a killed parasite vaccine.

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900172-9

7 January 2021

Long-term immunological response induced by attenuated Trypanosoma cruzi in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900172-9

7 January 2021

Trypanosoma cruzi: protection in mice immunized with 8-methoxypsoralen-inactivated trypomastigotes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900172-9

7 January 2021

Antigens of the Subcellular Fractions ofTrypanosoma cruzi. II. Flagellar and Membrane Fraction*

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900172-9

7 January 2021

Trypanosoma cruzi: immune response in mice immunized with parasite antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900172-9

7 January 2021

Trypanosoma cruzi: cellular and antibody response against the parasite in mice immunized with a 19-amino acid synthetic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900172-9

7 January 2021

Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900172-9

7 January 2021

Corynebacterium parvumas an adjuvant forTrypanosoma cruziepimastigote vaccines: a comparison with saponin andBordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900172-9

7 January 2021

Immunoprotection of mice against Trypanosoma cruzi with a lyophilized flagellar fraction of the parasite plus adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900172-9

7 January 2021

Immunization against Trypanosoma cruzi: adjuvant effect of glucan

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900172-9

7 January 2021

Enhancement of host resistance against Trypanosoma cruzi infection by the immunoregulatory agent muramyl dipeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900172-9

7 January 2021

Trypanosoma cruzi: protective immunity in mice immunized with paraflagellar rod proteins is associated with a T-helper type 1 response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900172-9

7 January 2021

Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900172-9

7 January 2021

CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900172-9

7 January 2021

Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900172-9

7 January 2021

Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900172-9

7 January 2021

Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900172-9

7 January 2021

CpG motifs as immune adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900172-9

7 January 2021

Bacterial DNA as immune cell activator

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900172-9

7 January 2021

CpG motifs in bacterial DNA trigger direct B-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900172-9

7 January 2021

The role of CpG dinucleotides in DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900172-9

7 January 2021

Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900172-9

7 January 2021

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900172-9

7 January 2021

Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900172-9

7 January 2021

The regulation of immunity to Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900172-9

7 January 2021

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900172-9

7 January 2021

Host genetics and resistance to acute Trypanosoma cruzi infection in mice. I. Antibody isotype profiles

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900172-9

7 January 2021

Role of nitric oxide in resistance and histopathology during experimental infection with Trypanosoma cruzi.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900172-9

7 January 2021

10.1016/S0264-410X(00)00172-9

Identifiers

DOI

1 reference

23 September 2017

1 reference